Dexlansoprazole
Product Images NDC 70518-3693

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 70518-3693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Dexlansoprazole delayed-release capsules, 60 mg strength, in a quantity of 30 capsules. The label includes the NDC number 70518-3693-00 and is repackaged by RemedyRepack Inc. It shows a warning about FD&C Yellow No. 5 (tartrazine), storage temperature guidelines, and contact information for RemedyRepack Inc.*

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

Chemical structure of dexlansoprazole depicted with its molecular bonds and functional groups, corresponding to the active ingredient in the product by REMEDYREPACK INC.*

FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

A line graph depicting plasma concentration (ng/mL) over time (hours) for dexlansoprazole at 30 mg and 60 mg doses. The graph shows two distinct curves: a dashed line with downward triangles for 30 mg, and a solid line with circles for 60 mg, illustrating concentration changes up to 24 hours post-administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.